Rockwell Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	27	33	69	55	12	39
Market Cap Growth	-22.85%	-52.73%	26.19%	348.15%	-68.12%	-59.23%
Enterprise Value	17.66	20.32	61.41	57.56	8.79	52.37
Last Close Price	6.88	8.34	20.40	18.90	10.10	45.10
Forward PE	-	132.86	132.86	47.17	47.17	47.17
PEG Ratio	-	2.36	2.36	2.36	2.36	2.36
PS Ratio	0.40	0.47	0.68	0.66	0.17	0.62
PB Ratio	0.76	0.89	2.13	2.59	0.87	15.20
P/TBV Ratio	1.01	1.14	2.95	4.59	1.10	23.83
P/FCF Ratio	15.46	-	21.77	-	-	-
P/OCF Ratio	10.21	-	16.53	-	-	-
EV/Sales Ratio	0.26	0.29	0.61	0.69	0.12	0.85
EV/EBITDA Ratio	-	-	12.93	-	-	-
EV/EBIT Ratio	-	-	101.00	-	-	-
EV/FCF Ratio	10.05	-	19.24	-	-	-
Debt / Equity Ratio	0.35	0.29	0.35	0.54	1.02	10.61
Debt / EBITDA Ratio	-	-	2.85	-	-	-
Debt / FCF Ratio	8.59	-	4.24	-	-	-
Net Debt / Equity Ratio	-0.24	-0.34	-0.25	0.12	-0.25	5.46
Net Debt / EBITDA Ratio	17.17	34.99	-1.70	-0.78	0.25	-0.50
Net Debt / FCF Ratio	-5.00	10.43	-2.53	-0.26	0.20	-0.41
Asset Turnover	1.18	1.19	1.82	1.69	1.53	0.98
Inventory Turnover	17.33	12.51	14.42	12.82	13.90	16.11
Quick Ratio	3.32	3.46	2.12	1.31	1.57	1.35
Current Ratio	3.74	3.98	2.63	1.73	2.00	1.68
Return on Equity (ROE)	-14.84%	-15.28%	-1.78%	-51.31%	-224.59%	-178.04%
Return on Assets (ROA)	-8.40%	-8.06%	1.09%	-13.50%	-35.25%	-48.03%
Return on Invested Capital (ROIC)	-18.68%	-19.16%	2.52%	-38.78%	-124.38%	-383.98%
Return on Capital Employed (ROCE)	-10.12%	-10.12%	1.51%	-20.69%	-59.34%	-65.55%
FCF Yield	6.47%	-	4.59%	-	-	-
Buyback Yield / Dilution	-15.65%	-15.83%	-33.17%	-63.05%	-67.77%	-24.02%
Total Shareholder Return	-15.65%	-15.83%	-33.17%	-63.05%	-67.77%	-24.02%

SEC Filings: 10-K · 10-Q